SRX Global Inc (SRXH) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SRXH SEC filings page.
SRX Global Inc (SRXH) reported $6.5M in revenue for fiscal year 2025, down 81.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025 shows a sharply smaller business whose costs remained too high for its revenue, leaving operations dependent on fresh financing.
Cash conversion deteriorated as scale fell: revenue declined from$35.0M in FY2024 to$6.5M in FY2025, while operating cash outflow widened from$4.4M to$8.1M . That combination indicates the cost structure did not contract with activity; operating cash use exceeded FY2025 revenue, rather than merely reflecting an accounting loss.
Margin compression was operational, not just below-the-line: gross margin fell from
The financing profile changed materially: FY2025 reported no long-term debt and a current ratio of
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of SRX Global Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
SRX Global Inc held $1.3M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $8.1M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and SRX Global Inc scores 8/100 among other emerging companies.
SRX Global Inc had 27M shares outstanding at the end of fiscal year 2025, against 2M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and SRX Global Inc scores 3/100 among other emerging companies.
Not available for SRX Global Inc, and counted as zero in the overall score.
SRX Global Inc reported revenue of $6.5M in fiscal year 2025, against $35.0M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and SRX Global Inc scores 3/100 among other emerging companies.
Not available for SRX Global Inc, and counted as zero in the overall score.
SRX Global Inc's cash, cash equivalents and investments came to $1.3M at the end of fiscal year 2025, against $8.0M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and SRX Global Inc scores 24/100 among other emerging companies.
SRX Global Inc scores -4.80, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($27.6M) relative to total liabilities ($8.0M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
SRX Global Inc passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). No profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
SRX Global Inc reported an operating loss of $11.4M against $628K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
SRX Global Inc generated $3.4M in revenue in Q3 2026. This represents an increase of 26.9% from the same quarter a year earlier. Against the prior quarter it is down 1.4%.
SRX Global Inc's EBITDA was -$3.2M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 62.0% from the same quarter a year earlier. Against the prior quarter it is down 83.6%.
SRX Global Inc reported -$4.1M in net income in Q3 2026. This represents an increase of 72.6% from the same quarter a year earlier. Against the prior quarter it is up 35.1%.
Cash & Balance Sheet
SRX Global Inc held $35.2M in cash against $0 in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
SRX Global Inc's gross margin was 26.7% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 25.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 10.4 percentage points.
SRX Global Inc's operating margin was -94.4% in Q3 2026, reflecting core business profitability. Against the prior quarter it is down 41.5 percentage points. No change is given against Q3 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
SRX Global Inc's ROE was -2.9% in Q3 2026, measuring profit generated per dollar of shareholder equity. Against the prior quarter it is up 32.0 percentage points.
Not shown for Q3 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
SRX Global Inc repurchased no shares in Q3 2026. This represents a decrease of 100.0% from the same quarter a year earlier.
Not reported for Q3 2026.
Not reported for Q3 2026.
SRXH Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'26S-4/A | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.4M+26.9% | $3.4M-52.0% | $2.8M | N/A | $2.7M-93.7% | $7.2M-9.4% | N/A | $11.4M-13.3% |
| Cost of Revenue | $2.5M-5.8% | $2.2M-54.7% | $1.8M | N/A | $2.6M-92.1% | $4.8M-9.7% | N/A | $6.9M-21.0% |
| Gross Profit | $904K+2816.1% | $1.3M-46.5% | $1.1M | N/A | $31K-99.7% | $2.4M-8.8% | N/A | $4.5M+1.8% |
| SG&A Expenses | $4.1M-52.5% | $3.1M-10.9% | $4.8M | N/A | $8.6M-19.6% | $3.5M-31.7% | N/A | $5.6M-20.0% |
| Operating Income | -$3.2M+62.8% | -$1.8M-67.1% | -$3.8M | N/A | -$8.6M-551.0% | -$1.1M+55.9% | N/A | -$1.1M+56.9% |
| EBITDA | -$3.2M+62.0% | -$1.7M-63.7% | -$3.8M | N/A | -$8.4M-649.2% | -$1.1M+56.3% | N/A | -$1.1M+49.6% |
| Interest Expense | $569K+1996.7% | $1.8M+2044.6% | $1.3M | N/A | -$30K-116.7% | $83K-77.1% | N/A | $6K+101.7% |
| Income Tax | N/A | $2K0.0% | $4K | N/A | $138K-60.0% | $2K0.0% | N/A | -$2K |
| Net Income | -$4.1M+72.6% | -$6.4M+37.1% | -$8.6M-116.3% | N/A | -$15.1M-385.8% | -$10.1M-258.6% | -$4.0M+72.9% | $1.5M+194.1% |
| EPS (Basic) | -$0.36+99.2% | -$0.02+94.9% | -$0.26-52.9% | -$0.59-180.8% | -$44.51-31692.9% | -$0.39+89.2% | -$0.17+99.2% | $0.73+131.7% |
| EPS (Diluted) | -$0.36 | -$0.02 | -$0.26 | -$0.59 | -$44.51 | -$0.39 | -$0.17 | $0.73 |
| Diluted Shares (Avg) | 11M | 299M | 34M | N/A | 340,019 | 26M | 24M | 2M |
Not reported in any period shown, so not listed: R&D Expenses.
SRXH Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'26S-4/A | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $145.4M+327.7% | $43.4M+183.6% | $27.1M+71.2% | $8.4M-75.1% | $34.0M+159.7% | $15.3M-1.0% | $15.8M-5.6% | $33.8M+8.7% |
| Current Assets | $65.2M+166.0% | $43.1M+197.0% | $18.8M+25.6% | $8.1M-40.4% | $24.5M+100.8% | $14.5M-0.4% | $15.0M-7.6% | $13.6M-34.8% |
| Cash & Equivalents | $35.2M+3758.1% | $20.5M+1706.8% | $13.1M+326.0% | $1.3M+1134.9% | $912K-72.3% | $1.1M-70.7% | $3.1M-31.2% | $106K-97.2% |
| Short-Term Investments | $7.5M | $3.0M | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $2.6M-49.1% | $2.1M-53.8% | $1.3M-65.9% | $2.1M-38.3% | $5.1M+34.2% | $4.5M-13.2% | $3.9M-41.5% | $3.4M-55.3% |
| Accounts Receivable | $3.6M-55.4% | $3.8M-20.2% | $3.1M-43.1% | $3.9M-57.5% | $8.1M+88.2% | $4.8M+9.9% | $5.4M+23.4% | $9.3M+8.1% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | N/A | N/A | N/A | N/A | N/A | $405K0.0% | $405K | $405K-97.8% |
| Total Liabilities | $2.4M-97.0% | $25.1M-66.1% | $23.5M-70.4% | $8.0M-91.0% | $79.9M+129.7% | $74.0M+417.0% | $79.5M+477.6% | $88.9M+37.1% |
| Current Liabilities | $2.4M-96.8% | $25.1M+242.6% | $23.5M+229.2% | $3.5M-95.6% | $74.1M+713.5% | $7.3M-48.7% | $7.1M-47.8% | $81.3M+517.1% |
| Non-Current Liabilities | $0-100.0% | $0-100.0% | $0-100.0% | $4.5M-41.3% | $5.8M+15459.5% | $5K-90.4% | $5K-92.5% | $7.6M+171.1% |
| Long-Term Debt | $0-100.0% | $0 | N/A | $0-100.0% | $1.9M | N/A | $2.4M-47.8% | $696K-74.4% |
| Total Equity | $143.0M+411.7% | $18.3M+131.1% | $3.5M+105.5% | $407K+100.7% | -$45.9M-111.6% | -$58.7M-5473.8% | -$63.7M-2260.6% | -$55.1M-63.2% |
| Retained Earnings | -$42.1M+57.3% | -$37.9M+88.2% | -$31.5M+90.2% | -$22.9M+67.3% | -$98.4M+69.4% | -$322.5M+0.5% | -$321.5M-0.1% | -$70.0M+77.2% |
SRXH Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'26S-4/A | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | -$6.6M-1825.8% | -$2.9M-299.7% | $7.6M+445.0% | -$15.8M-79180.0% | $384K+138.2% | $1.5M+47.6% | -$2.2M-742.3% |
| Depreciation & Amortization | $10K-95.0% | $80K+207.7% | $15K-98.4% | N/A | $200K0.0% | $26K-25.7% | $920K+121.2% | $20K-95.2% |
| Stock-Based Compensation | $0-100.0% | $0-100.0% | $961K+126.7% | N/A | $2.9M+262.5% | $280K-45.9% | $424K | $100K-80.0% |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | $7K+133.3% | $12K+50.0% | $11K |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | $377K+137.4% | $1.5M+47.6% | -$2.2M-745.5% |
| Investing Cash Flow | N/A | -$7.0M-524.0% | -$8.5M-414.3% | -$7.4M-404.8% | $9.6M+64020.0% | -$1.1M-37466.7% | $2.7M+33750.0% | -$1.5M |
| Financing Cash Flow | $25.8M+659.1% | $21.1M+1882.7% | $23.1M+751.6% | $12.6M+145.6% | $3.4M+677.9% | -$1.2M-375.8% | -$3.5M-982.3% | $5.1M+3509.3% |
| Share Buybacks | $0-100.0% | N/A | N/A | $0 | -$56K | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
SRXH Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'26S-4/A | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 26.7%+25.5pp | 37.1%+3.8pp | 37.5% | N/A | 1.2%-20.9pp | 33.3%+0.2pp | N/A | 39.7%+5.9pp |
| Operating Margin | -94.4% | -52.9%-37.7pp | -135.0% | N/A | -322.0% | -15.2%+16.0pp | N/A | -9.9%+10.0pp |
| Net Margin | -122.0% | -185.5% | -306.9% | N/A | -566.1% | -141.8% | N/A | 13.4%+25.8pp |
| Return on Equity | -2.9% | -34.9% | -244.4% | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -2.9%+41.7pp | -14.7%+51.7pp | -31.8%-6.6pp | N/A | -44.5%-20.7pp | -66.4%-48.1pp | -25.2%+62.6pp | 4.5%+9.7pp |
| Current Ratio | 27.55+27.2x | 1.72-0.3x | 0.80-1.3x | 2.29+2.1x | 0.33-1.0x | 1.99+1.0x | 2.10+0.9x | 0.17-1.4x |
| Debt-to-Equity | 0.00 | 0.00 | 6.68 | 0.00 | N/A | N/A | N/A | N/A |
| Asset Turnover | 0.02-0.1x | 0.08-0.4x | 0.10 | N/A | 0.08-3.2x | 0.470.0x | N/A | 0.34-0.1x |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | 5.3%+18.0pp | N/A | -19.5%-22.1pp |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| SRX Global Inc SRXH | FY2025 | $6.5M | N/A | N/A | $27.6M | 6/100 |
| American Shared Hospital Services AMS | FY2025 | $28.1M | -$1.6M | -5.5% | $8.4M | 37/100 |
| ModivCare Inc. MODV | FY2024 | $2.8B | -$201.3M | -7.2% | $6.2M | 20/100 |
| Concord Medical Services Holding Limited CCM | FY2025 | $65.9M | -$13.3M | -20.2% | $16.5M | 29/100 |
| NewGenIvf Group Limited NIVF | FY2025 | $4.7M | $9.9M | N/A | $1.6M | 31/100 |
Where SRX Global Inc Ranks
Frequently Asked Questions
What is SRX Global Inc's annual revenue?
SRX Global Inc (SRXH) reported $6.5M in total revenue for fiscal year 2025. This represents a -81.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is SRX Global Inc's revenue growing?
SRX Global Inc (SRXH) revenue declined by 81.3% year-over-year, from $35.0M to $6.5M in fiscal year 2025.
What is SRX Global Inc's EBITDA?
SRX Global Inc (SRXH) had EBITDA of -$11.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does SRX Global Inc have?
As of fiscal year 2025, SRX Global Inc (SRXH) had $1.3M in cash and equivalents against $0 in long-term debt.
What is SRX Global Inc's gross margin?
SRX Global Inc (SRXH) had a gross margin of 23.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is SRX Global Inc's operating cash flow?
SRX Global Inc (SRXH) recorded an outflow of $8.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are SRX Global Inc's total assets?
SRX Global Inc (SRXH) had $8.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What is SRX Global Inc's current ratio?
SRX Global Inc (SRXH) had a current ratio of 2.29 as of fiscal year 2025, which is generally considered healthy.
What is SRX Global Inc's debt-to-equity ratio?
SRX Global Inc (SRXH) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is SRX Global Inc's P/E ratio?
SRX Global Inc (SRXH) has no price-to-earnings ratio at the moment: no net income reported. The market capitalization is $27.6M as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is SRX Global Inc's price-to-sales ratio?
SRX Global Inc (SRXH) trades at 4.2x sales, its market capitalization divided by revenue of $6.5M revenue, FY2025. The market capitalization is $27.6M as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does SRX Global Inc's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, SRX Global Inc (SRXH) held $1.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $8.1M over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is SRX Global Inc's Altman Z-Score?
SRX Global Inc (SRXH) has an Altman Z-Score of -4.80, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is SRX Global Inc's Piotroski F-Score?
SRX Global Inc (SRXH) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Can SRX Global Inc cover its interest payments?
SRX Global Inc (SRXH) reported an operating loss of $11.4M against $628K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is SRX Global Inc?
SRX Global Inc (SRXH) scores 6 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.